The DSMB acts as a safeguard for study participants. By continuously monitoring the data, they can ensure that any new information that could affect participant safety is quickly addressed. This might involve altering the dosage, changing study procedures, or providing additional information to participants about new risks or benefits. In severe cases, the DSMB can recommend halting the trial to protect participants from harm.
